Literature DB >> 2893159

Interferon in myelofibrosis.

H Hasselbalch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2893159     DOI： 10.1016/s0140-6736(88)91144-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Cytoreductive effect of recombinant alpha interferon in patients with myelofibrosis with myeloid metaplasia.

Authors:  G Barosi; L N Liberato; A Costa; E Ascari
Journal:  Blut       Date:  1989-06

2.  The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML--a comparative morphometric study on sequential trephine biopsies.

Authors:  J Thiele; H M Kvasnicka; N Niederle; T K Zirbes; M Schmidt; J Dammasch; B R Meuter; L D Leder; O Kloke; V Diehl
Journal:  Ann Hematol       Date:  1995-03       Impact factor: 3.673

Review 3.  Next Generation Sequencing in MPNs. Lessons from the Past and Prospects for Use as Predictors of Prognosis and Treatment Responses.

Authors:  Vibe Skov
Journal:  Cancers (Basel)       Date:  2020-08-06       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.